Edwards Lifesciences Corporation News
Cramer's Mad Money Recap 5/2: Coca-Cola, American Express, Visa
Investors can't wait for inflation to be broken before they buy.
Cramer's Mad Money Recap 2/1: Colgate-Palmolive, Stanley Black & Decker
Jim Cramer says stocks are caught between the forces of inflation and deflation, and investors need to find companies that can adapt.
Jim Cramer Talks With CEO of Edwards Lifesciences
Medical device maker doubling down on heart valve research, CEO Michael Mussallem tells Cramer.
Cramer's Mad Money Recap 12/8: Pfizer, Sweetgreen, Edwards Lifesciences
Jim Cramer reminds us the Dow has soared from 1,000 to 35,000 over the course of his career. That's quite a run, despite all the investor negativity.
'Mad Money' Lightning Round: Snap, Boston Scientific
Jim Cramer’s bullish on Snap, Boston Scientific and Cleveland-Cliffs.
Cramer's Mad Money Recap: Netflix, Apple
Jim Cramer says the FAANG stocks get the benefit of the doubt, and they deserve it.
Edward Lifesciences Hits Record High After Earnings Beat, TAVR Forecast
Edwards Lifesciences said its sees transcatheter aortic valve replacement (TAVR) sales rising as high as 20% this year.
Reopening Plays: Cramer's 'Mad Money' Recap (Monday 3/1/21)
Jim Cramers sifts through this relentless run in the reopening plays to find the less-obvious companies poised for profit.
Don't Bet Against the Bulls: Cramer's 'Mad Money' Recap (Thursday 12/10/20)
Despite the IPO euphoria, the backdrop to this market is just too optimistic to bet against the bulls, Jim Cramer says.
Vaccine Hopes: Cramer's 'Mad Money' Recap (Wednesday 7/15/20)
Jim Cramer says the markets are optimistic about a vaccine, but he cautions there’s a long way to go. We still need more stimulus.
Breaking News
Johnson & Johnson Stock Lower After Unveiling End To Global Baby Powder Sales In 2023
Johnson & Johnson, which began selling Baby Powder in 1894, will end all sales of the talc-based product next year.
Apple Stock Edges Higher After Report Indicates iPhone Demand Confidence
Apple is asking assemblers to put together 220 million iPhones this year, Bloomberg reported, a tally that largely matches 2021 levels.
Struggling Electric-Truck Maker Nikola Makes a Major Change
Electric-truck manufacturer Nikola, like the broad vehicle industry, has been struggling with supply-chain issues.
Illumina and the Quest for the (Holy?) Grail
DNA-sequencing leader Illumina swung to a loss in Q2 2022. Contributions from Grail didn't help.